Daxor Stock (NASDAQ:DXR)


OwnershipChart

Previous Close

$10.45

52W Range

$8.56 - $14.76

50D Avg

$10.36

200D Avg

$11.65

Market Cap

$59.61M

Avg Vol (3M)

$4.40K

Beta

0.26

Div Yield

$0.06

DXR Company Profile


Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer. This diagnostic instrument offers a precise, objective method for quantifying a patient's blood volume status and composition, comparing these metrics against their unique physiological norms. It is utilized across a wide spectrum of medical and surgical contexts. Prior to May 1973, the organization operated under the name Idant Corporation.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

37

IPO Date

Jul 25, 1983

Website

DXR Performance


Latest Earnings Call Transcripts


Q4 24Mar 06, 25 | 4:30 PM
Q4 23Mar 25, 24 | 4:00 PM
Q4 22Mar 02, 23 | 9:00 AM

Peer Comparison


TickerCompany
LITSLite Strategy, Inc.
NEPHNephros, Inc.
CRVOCervoMed Inc.
NRXPNRx Pharmaceuticals, Inc.
ADAGAdagene Inc.
XBITXBiotech Inc.
BEATHeartBeam, Inc.
GEGGreat Elm Group, Inc.
GANXGain Therapeutics, Inc.
ACETAdicet Bio, Inc.